Literature DB >> 9480845

TGF-beta-activated kinase 1 stimulates NF-kappa B activation by an NF-kappa B-inducing kinase-independent mechanism.

H Sakurai1, N Shigemori, K Hasegawa, T Sugita.   

Abstract

Several mitogen-activated protein kinase kinase kinases (MAPKKKs), including NF-kappa B-inducing kinase (NIK), play critical roles in NF-kappa B activation. We isolated cDNA for human TGF-beta activated kinase 1 (TAK1), a member of the MAPKKK family, and evaluated its ability to stimulate NF-kappa B activation. Overexpression of TAK1 together with its activator protein, TAK1 binding protein 1 (TAB1), induced the nuclear translocation of NF-kappa B p50/p65 heterodimer accompanied by the degradation of I kappa B alpha and I kappa B beta, and the expression of kappa B-dependent reporter gene. A dominant negative mutant of NIK did not inhibit TAK1-induced NF-kappa B activation. These results suggest that TAK1 induces NF-kappa B activation through a novel NIK-independent signaling pathway.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9480845     DOI: 10.1006/bbrc.1998.8124

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  26 in total

1.  Receptor activator of NF-kappaB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6.

Authors:  Junko Mizukami; Giichi Takaesu; Hiroyuki Akatsuka; Hiroaki Sakurai; Jun Ninomiya-Tsuji; Kunihiro Matsumoto; Naoki Sakurai
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

2.  Structure-guided development of covalent TAK1 inhibitors.

Authors:  Li Tan; Deepak Gurbani; Ellen L Weisberg; John C Hunter; Lianbo Li; Douglas S Jones; Scott B Ficarro; Samar Mowafy; Chun-Pong Tam; Suman Rao; Guangyan Du; James D Griffin; Peter K Sorger; Jarrod A Marto; Kenneth D Westover; Nathanael S Gray
Journal:  Bioorg Med Chem       Date:  2016-12-09       Impact factor: 3.641

Review 3.  NF-κB inducing kinase: a key regulator in the immune system and in cancer.

Authors:  Yee Mon Thu; Ann Richmond
Journal:  Cytokine Growth Factor Rev       Date:  2010-08-03       Impact factor: 7.638

4.  Mutations in the Drosophila dTAK1 gene reveal a conserved function for MAPKKKs in the control of rel/NF-kappaB-dependent innate immune responses.

Authors:  S Vidal; R S Khush; F Leulier; P Tzou; M Nakamura; B Lemaitre
Journal:  Genes Dev       Date:  2001-08-01       Impact factor: 11.361

5.  The relationship between members of the canonical NF-kB pathway, tumour microenvironment and cancer specific survival in colorectal cancer patients.

Authors:  Jean A Quinn; Lindsay Bennett; Meera Patel; Mikaela Frixou; James H Park; Antonia Roseweir; Paul G Horgan; Donald C McMillan; Joanne Edwards
Journal:  Histol Histopathol       Date:  2019-10-08       Impact factor: 2.303

6.  Enhancement of lipopolysaccharide-stimulated JNK activity in rat aortic smooth muscle cells by pharmacological and adenovirus-mediated inhibition of inhibitory kappa B kinase signalling.

Authors:  Christopher J MacKenzie; Andrew Paul; Susan Wilson; Rainer de Martin; Andrew H Baker; Robin Plevin
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

7.  TAB4 stimulates TAK1-TAB1 phosphorylation and binds polyubiquitin to direct signaling to NF-kappaB.

Authors:  Todd D Prickett; Jun Ninomiya-Tsuji; Peter Broglie; Tara L Muratore-Schroeder; Jeffrey Shabanowitz; Donald F Hunt; David L Brautigan
Journal:  J Biol Chem       Date:  2008-05-02       Impact factor: 5.157

8.  Resistin up-regulates COX-2 expression via TAK1-IKK-NF-kappaB signaling pathway.

Authors:  Jian Zhang; Ting Lei; Xiaodong Chen; Yin Peng; Huan Long; Lei Zhou; Jianfeng Huang; Zhilong Chen; Qinqiang Long; Zaiqing Yang
Journal:  Inflammation       Date:  2010-02       Impact factor: 4.092

9.  Memory T cell RNA rearrangement programmed by heterogeneous nuclear ribonucleoprotein hnRNPLL.

Authors:  Zuopeng Wu; Xinying Jia; Laura de la Cruz; Xun-Cheng Su; Bruz Marzolf; Pamela Troisch; Daniel Zak; Adam Hamilton; Belinda Whittle; Di Yu; Daniel Sheahan; Edward Bertram; Alan Aderem; Gottfried Otting; Christopher C Goodnow; Gerard F Hoyne
Journal:  Immunity       Date:  2008-12-19       Impact factor: 31.745

10.  Mutations in MAP3K7 that Alter the Activity of the TAK1 Signaling Complex Cause Frontometaphyseal Dysplasia.

Authors:  Emma M Wade; Philip B Daniel; Zandra A Jenkins; Aideen McInerney-Leo; Paul Leo; Tim Morgan; Marie Claude Addor; Lesley C Adès; Debora Bertola; Axel Bohring; Erin Carter; Tae-Joon Cho; Hans-Christoph Duba; Elaine Fletcher; Chong A Kim; Deborah Krakow; Eva Morava; Teresa Neuhann; Andrea Superti-Furga; Irma Veenstra-Knol; Dagmar Wieczorek; Louise C Wilson; Raoul C M Hennekam; Andrew J Sutherland-Smith; Tim M Strom; Andrew O M Wilkie; Matthew A Brown; Emma L Duncan; David M Markie; Stephen P Robertson
Journal:  Am J Hum Genet       Date:  2016-07-15       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.